Table 2.
Parameter | Frequency (%)/Median (IQR) |
Socio-demographic and risk factors | |
Age (years) | 42 (32–55) |
Male sex | 52 (61.2%) |
Alcohol use | 47 (55.3%) |
HBsAg positive | 23 (27.1%) |
HCV antibody positive | 3 (3.5%) |
HIV positive | 13 (15.3%) |
Clinical features | |
Jaundice | 53 (62.4%) |
Lower limb oedema | 68 (80%) |
Collateral veins | 39 (45.9%) |
Splenomegaly | 37 (43.5%) |
Variceal bleeding | 31 (36.5%) |
Encephalopathy | |
Grade 1 and 2 | 15 (17.6%) |
Grade 3 and 4 | 5 (5.9%) |
Ascites | 81 (95.3%) |
Child Pugh class | |
B | 23 (27.1%) |
C | 62 72.9% |
Laboratory findings | |
Alanine aminotransferase ( IU/L) | 28.8 (21.1–52.8) |
Aspartate aminotransferase ( IU/L) | 76.3 (43.5–128.5) |
Serum bilirubin (mg/dL) | 2.1 (0.8–5.6) |
Serum albumin (g/dL) | 2.1 (1.7–2.5) |
International Normalized Ratio | 2.1 (1.6–2.8) |
Prothrombin time (seconds) | 22.1 (18.7–27.6) |
Platelet count (×103/µl) | 121 (64–210) |
Haemoglobin (g/dL) | 9.8 (8.1–12.1) |